Want to see JP:9820 full AI Analyst Report?

MT Genex Corporation (9820) Price & Analysis

0 Followers

9820 Stock Chart & Stats

¥3500.00

-¥45.00(-1.75%)

At close: Jan 08 4:00 PM EST

¥3500.00

-¥45.00(-1.75%)

Day’s Range― - ―

52-Week Range¥3,000.00 - ¥4,290.00

Previous CloseN/A

Volume300.00

Average Volume (3M)926.00

Market Cap

¥3.95B

Enterprise Value¥1.85B

Total Cash (Recent Filing)¥1.99B

Total Debt (Recent Filing)¥84.66M

Price to Earnings (P/E)12.5

Beta0.12

Next Earnings

Aug 07, 2026

EPS EstimateN/A

Next Dividend Ex-DateN/A

Dividend Yield1.11%

Share Statistics

EPS (TTM)292.55

Shares Outstanding1,079,600

10 Day Avg. Volume840

30 Day Avg. Volume926

Financial Highlights & Ratios

PEG Ratio0.64

Price to Book (P/B)0.85

Price to Sales (P/S)0.80

P/FCF Ratio68.41

Enterprise Value/Market CapN/A

Enterprise Value/RevenueN/A

Enterprise Value/Gross ProfitN/A

Enterprise Value/EbitdaN/A

Forecast

1Y Price TargetN/A

Price Target UpsideN/A

Rating ConsensusN/A

Number of Analyst Covering0

EPS Forecast (FY)N/A

Revenue Forecast (FY)N/A

Bulls Say, Bears Say

Bulls Say

Conservative Balance SheetExtremely low leverage (debt-to-equity ~0.02) and a conservative balance sheet materially reduce refinancing and solvency risk. This financial conservatism supports resilience through cycles, allows opportunistic investment or buybacks, and preserves long-term financial flexibility.

Accelerating Revenue GrowthRevenue growth accelerated to ~15.8% in FY2026, indicating expanding market penetration or product adoption. Sustained top-line momentum supports scale benefits, improves the potential for operating leverage, and underpins durable earnings growth if the trend continues.

Meaningful Free Cash FlowFree cash flow equating to ~69% of net income provides internal funding for capex, dividends, or strategic initiatives. Positive FCF reduces reliance on external financing and enhances long-term financial flexibility, supporting durable capital allocation even with some OCF volatility.

Bears Say

Weak Operating Cash ConversionOperating cash flow covering only ~9% of net income and sharp year-on-year decline signals weak earnings-to-cash conversion. Persistent working-capital drag or collection issues can constrain reinvestment, increase financing needs, and reduce confidence in earnings quality over the medium term.

Margin CompressionMargins have compressed versus earlier years, with gross margin in the low-to-mid 20% range and net margin near ~6.7%. Ongoing margin pressure from cost increases or mix shifts undermines operating leverage and can materially reduce sustainable profit growth unless structural cost or pricing actions are taken.

Modest Return On EquityROE around ~7% reflects steady but modest capital productivity. While safety is strong, limited returns constrain the company’s ability to compound shareholder value and suggest that without efficiency gains or higher-return initiatives, long-term upside from existing operations may be muted.

9820 FAQ

What was MT Genex Corporation’s price range in the past 12 months?

MT Genex Corporation lowest stock price was ¥3000.00 and its highest was ¥4290.00 in the past 12 months.

What is MT Genex Corporation’s market cap?

MT Genex Corporation’s market cap is ¥3.95B.

When is MT Genex Corporation’s upcoming earnings report date?

MT Genex Corporation’s upcoming earnings report date is Aug 07, 2026 which is in 8 days.

How were MT Genex Corporation’s earnings last quarter?

MT Genex Corporation released its earnings results on May 11, 2026. The company reported ¥97.67 earnings per share for the quarter, beating the consensus estimate of N/A by ¥97.67.

Is MT Genex Corporation overvalued?

According to Wall Street analysts MT Genex Corporation’s price is currently Overvalued. Get more investment ideas with TipRanks Premium

Does MT Genex Corporation pay dividends?

MT Genex Corporation pays a Annually dividend of ¥40 which represents an annual dividend yield of 1.11%. See more information on MT Genex Corporation dividends here

What is MT Genex Corporation’s EPS estimate?

MT Genex Corporation’s EPS estimate for its next earnings report is not yet available.

How many shares outstanding does MT Genex Corporation have?

MT Genex Corporation has 1,079,600 shares outstanding.

What happened to MT Genex Corporation’s price movement after its last earnings report?

MT Genex Corporation reported an EPS of ¥97.67 in its last earnings report, beating expectations of N/A. Following the earnings report the stock price went down -0.972%.

Which hedge fund is a major shareholder of MT Genex Corporation?

Currently, no hedge funds are holding shares in JP:9820

What is the TipRanks Smart Score and how is it calculated?

Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology

Company Description

MT Genex Corporation

MT Genex Corporation, along with its group of companies, serves as a specialist contractor for both new construction and refurbishment of homes and commercial premises throughout Japan. Its activities are structured across four primary divisions: Renovation Services, Parking Solutions, Facilities Upkeep & Management, and Insurance Brokering. The firm executes both interior and exterior building and property enhancement projects, offering comprehensive design and oversight for real estate developments. Additionally, it is responsible for the operation, administration, and leasing of parking areas, as well as the general management of real estate holdings. MT Genex also devises and proposes risk management strategies, encompassing a variety of non-life insurance offerings. Further expanding its portfolio, the company is engaged in real estate development, hotel operations, and the maintenance of electrical systems. Established in Tokyo, Japan, in 1945, MT Genex Corporation functions as a subsidiary of Mori Trust Co., Ltd.